Sort
15,842 grants matching “pancreatic cancer”
Systematic characterization of cancer variants using single-cell functional genomics
$418,693Thomas Maxwell Norman · Sloan-Kettering Inst Can Research · R33 · FY2024 · CA
Targeting pancreatic cancer's metabolic addiction to HuR
$418,473Jordan M Winter · Case Western Reserve University · R37 · FY2024 · CA
Inhibitors of the G protein GNAS which drives pancreatic tumorigenesis
$418,325Kevan M. Shokat · University Of California, San Francisco · R01 · FY2020 · CA
Basis for Lymphomagenesis in Akt2 Transgenic Mice
$418,237Joseph Robert Testa · Fox Chase Cancer Center · R01 · FY2009 · CA
Novel Inhibitors of Akt Signaling in Pancreatic Cancer
$418,213University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Novel Inhibitors of Akt Signaling in Pancreatic Cancer
$418,157Garth Powis · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
Role of Neurogenic Inflammation in Pancreatic Cancer
$418,087Brian M Davis · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
Transport Oncophysics Core
$418,062Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA
Mechanisms and Function of Autophagy in Cancer
$418,019Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Mechanisms and Function of Autophagy in Cancer
$418,019Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
$417,988Edna Cukierman · Research Inst Of Fox Chase Can Ctr · U54 · FY2022 · CA
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
$417,987Edna Cukierman · Research Inst Of Fox Chase Can Ctr · U54 · FY2025 · CA
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation
$417,810Laura D Attardi · Stanford University · P01 · FY2025 · CA
Validation of pancreatic cancer biomarkers in large prospective cohorts
$417,779Anna E Lokshin · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
$417,778Pietro Ferrari · International Agency For Res On Cancer · R01 · FY2018 · AA
Project 3 â Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC
$417,723Michael C Ostrowski · Medical University Of South Carolina · P01 · FY2023 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$417,605Murray Korc · Indiana University Indianapolis · R37 · FY2011 · CA
Helicobacter Pylori and Gastrointestinal Biology
$417,567Richard M Peek · Vanderbilt University Medical Center · R01 · FY2020 · DK
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$417,457Andrea Facciabene · University Of Pennsylvania · R01 · FY2016 · CA
Targeting Oncogenic Ras-MAPK Signaling Complexes via the Scaffold KSR
$417,453Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Targeting Oncogenic Ras-MAPK Signaling Complexes via the Scaffold KSR
$417,453Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Targeting Oncogenic Ras-MAPK Signaling Complexes via the Scaffold KSR
$417,453Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
SIAH2-Dependent Proteolysis in Cell Migration, Tumor Growth and Cancer Metastasis
$417,420Amy H. Tang · Eastern Virginia Medical School · R01 · FY2014 · CA
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy
$417,346Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2020 · CA
P-4: Direct Delivery of Immune-modulating Therapies to the Pancreatic Tumor Site
$417,285Pinku Mukherjee · Mayo Clinic Rochester · P50 · FY2011 · CA